Announcements Trials
Browse Landscape

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 11Observational 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 12Rectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Ovarian Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Postoperative Complications 2Pathologic Complete Response 2Head and Neck Neoplasms 2Breast Cancer Patients 2Surgery 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1

Interventions

Surveys and Questionnaires 22Blood Specimen Collection 13niraparib 8Cytoreduction Surgical Procedures 8Hyperthermic Intraperitoneal Chemotherapy 7Interviews as Topic 6Immunohistochemistry 6olaparib 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Magnetic Resonance Spectroscopy 5Data Collection 5Carboplatin 5Amplified Fragment Length Polymorphism Analysis 5liposomal doxorubicin 4Geriatric Assessment 4Bevacizumab 41-dodecylpyridoxal 4Ultrasonography 3Trabectedin 3Therapeutics 3Poly(ADP-ribose) Polymerase Inhibitors 3Phlebotomy 3Observation 3Neoadjuvant Therapy 3Microarray Analysis 3Laparoscopy 3Gene Expression Profiling 3Flow Cytometry 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Ovarian Neoplasms × Neoadjuvant Therapy × Clear all
NCT07567573 2026-05-05

retroESGO ov1

European Society of Gynaecological Oncology

Completed
11,383 enrolled
Gynecologic

Ovarian Neoplasms, Postoperative Complications, Recurrence, Neoplasm, Residual

NCT06304922 2024-03-12

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

Assiut University

Unknown
45 enrolled
Gynecologic

Ovarian Neoplasms

NCT06223763 2024-01-25

SUROVA

Clinica Universidad de Navarra, Universidad de Navarra

Unknown
5,000 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡